Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgA: an immune glycoprotein.

Esther M Yoo1, Sherie L Morrison

  • 1Department of Microbiology, Immunology and Molecular Genetics, University of California, 609 Charles E. Young Drive, Los Angeles, CA 90095, USA. esthery@microbio.ucla.edu

Clinical Immunology (Orlando, Fla.)
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2024
Same author

Genetically engineered antibodies and their application to brain delivery.

Advanced drug delivery reviews·2022
Same author

89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model.

Molecular cancer therapeutics·2022
Same author

Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow.

Immunity·2019
Same author

Elastomeric sensor surfaces for high-throughput single-cell force cytometry.

Nature biomedical engineering·2019
Same author

Publisher Correction: Elastomeric sensor surfaces for high-throughput single-cell force cytometry.

Nature biomedical engineering·2019
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

The baseline vaginal immune milieu is an important determinant of the inflammatory response induced by penile-vaginal sex.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Immunoglobulin A (IgA) glycosylation impacts its protective functions and receptor binding. Understanding these carbohydrate structures is key to developing effective IgA-based therapeutics for immune protection.

Area of Science:

  • Immunology
  • Glycobiology
  • Biochemistry

Background:

  • Immunoglobulin A (IgA) is crucial for mucosal immunity.
  • IgA structure includes N-linked and O-linked glycans (IgA1).
  • Glycosylation influences IgA effector functions and receptor interactions.

Purpose of the Study:

  • To explore the role of IgA glycosylation in immune protection.
  • To understand how carbohydrate structures affect IgA function.
  • To guide the development of clinically useful IgA antibodies.

Main Methods:

  • Analysis of IgA glycosylation patterns.
  • Investigation of structure-function relationships.
  • Assessment of IgA binding to receptors.

Related Experiment Videos

Main Results:

  • Glycosylation (presence, absence, and structure) significantly impacts IgA effector functions.
  • Specific glycan structures influence IgA receptor binding.
  • Altered IgA glycosylation is linked to immune pathology.

Conclusions:

  • Understanding IgA glycan contributions is vital for immune protection.
  • Targeting glycosylation can enhance IgA-based therapies.
  • This knowledge aids in designing clinically viable therapeutic antibodies.